NFKB1 and breast carcinoma: This is the case for breast cancer, where the EMT-suppressing effect of CFTR (i.e., increase in the levels of E-cadherin and decrease in the levels of vimentin) was associated with its ability to inhibit both NF-κB and uPA [18].